• Explore /
  • Poster
  • / Avelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up.

Avelumab treatment for metastatic urothelial carcinoma in the phase Ib JAVELIN Solid Tumor Study: Updated safety and efficacy analysis with ≥ two years of follow-up.

Abstract Poster

Authors

Andrea Apolo

Andrea B. Apolo

National Cancer Institute, National Institutes of Health, Bethesda, MD

Andrea B. Apolo , John Allan Ellerton , Jeffrey R. Infante , Manish Agrawal , Michael S. Gordon , Raid Aljumaily , Carolyn D. Britten , Luc Dirix , Keun-Wook Lee , Matthew H. Taylor , Patrick Schoffski , Ding Wang , Alain Ravaud , Junyuan Xiong , Galit Rosen , James L. Gulley , Manish R. Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT01772004

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 425)

DOI

10.1200/JCO.2019.37.7_suppl.425

Abstract #

425

Poster Bd #

H16

Abstract Disclosures

Similar Posters

First Author: Andrea B. Apolo

First Author: Manish R. Patel

First Author: Manish R. Patel

First Author: Shubham Pant